这个消息是啥意思？# Stock
gw
1 楼
Aureon Biosciences, Inc., a US-based life science company that provides
clinical research services, has raised $16.83 million of a proposed $17.1
million private offering of debt and other security to be acquired upon
exercise of option, warrant or other right to acquire security.
Deal Value (US$ Million) 16.83
Deal Type Private Placement
Sub-Category None
Deal Status Completed: 2011-09-29
Deal Participants
Target (Company) Aureon Biosciences, Inc. (formerly Aureon Biosciences
Corporation; Aureon Laboratories, Inc.; Aurigen Bioscience, Inc.)
Acquirer (Company) Undisclosed Investors*
clinical research services, has raised $16.83 million of a proposed $17.1
million private offering of debt and other security to be acquired upon
exercise of option, warrant or other right to acquire security.
Deal Value (US$ Million) 16.83
Deal Type Private Placement
Sub-Category None
Deal Status Completed: 2011-09-29
Deal Participants
Target (Company) Aureon Biosciences, Inc. (formerly Aureon Biosciences
Corporation; Aureon Laboratories, Inc.; Aurigen Bioscience, Inc.)
Acquirer (Company) Undisclosed Investors*